Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 692

1.

Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.

Alemao E, Cawston H, Bourhis F, Al M, Rutten-van Molken M, Liao KP, Solomon DH.

Rheumatology (Oxford). 2017 Jan 12. pii: kew440. doi: 10.1093/rheumatology/kew440. [Epub ahead of print]

PMID:
28087832
2.

The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights.

Curtis JR, Chen L, Greenberg JD, Harrold L, Kilgore ML, Kremer JM, Solomon DH, Yun H.

Pharmacoepidemiol Drug Saf. 2016 Dec 28. doi: 10.1002/pds.4126. [Epub ahead of print]

PMID:
28028867
3.

A Quality Improvement Approach to Rheumatoid Arthritis Management With Biologic Disease-Modifying Antirheumatic Drugs: Assessing Variability in a Treatment Pathway.

Dave AJ, Tory HO, Awosogba JA, Coblyn JS, Bermas B, Solomon DH, Desai SP.

J Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474. No abstract available.

PMID:
28002163
4.

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.

Radner H, Lesperance T, Accortt NA, Solomon DH.

Arthritis Care Res (Hoboken). 2016 Dec 20. doi: 10.1002/acr.23171. [Epub ahead of print]

PMID:
27998029
5.

Use of large healthcare databases for rheumatology clinical research.

Desai RJ, Solomon DH.

Curr Opin Rheumatol. 2016 Dec 15. [Epub ahead of print]

PMID:
27984323
6.

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

Nissen SE, Yeomans ND, Solomon DH, L├╝scher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators..

N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593.

PMID:
27959716
7.

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.

Harrold LR, Reed GW, Solomon DH, Curtis JR, Liu M, Greenberg JD, Kremer JM.

Arthritis Res Ther. 2016 Dec 1;18(1):280.

8.

Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.

Cummings SR, Cosman F, Lewiecki EM, Schousboe JT, Bauer DC, Black DM, Brown TD, Cheung AM, Cody K, Cooper C, Diez-Perez A, Eastell R, Hadji P, Hosoi T, Jan De Beur S, Kagan R, Kiel DP, Reid IR, Solomon DH, Randall S.

J Bone Miner Res. 2017 Jan;32(1):3-10. doi: 10.1002/jbmr.3039.

PMID:
27864889
9.

Different Rating of Global Rheumatoid Arthritis (RA) Disease Activity in Multimorbid Patients with RA.

Radner H, Yoshida K, Tedeschi S, Studenic P, Frits M, Iannaccone C, Shadick NA, Weinblatt M, Aletaha D, Smolen JS, Solomon DH.

Arthritis Rheumatol. 2016 Nov 11. doi: 10.1002/art.39988. [Epub ahead of print]

PMID:
27860467
10.

Pain Severity in Relation to the Final Menstrual Period in a Prospective Multiethnic Observational Cohort: Results From the Study of Women's Health Across the Nation.

Lee YC, Karlamangla AS, Yu Z, Liu CC, Finkelstein JS, Greendale GA, Harlow SD, Solomon DH.

J Pain. 2016 Nov 9. pii: S1526-5900(16)30282-6. doi: 10.1016/j.jpain.2016.10.012. [Epub ahead of print]

PMID:
27836812
11.

Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity.

Deshpande BR, Katz JN, Solomon DH, Yelin EH, Hunter DJ, Messier SP, Suter LG, Losina E.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1743-1750. doi: 10.1002/acr.22897.

PMID:
27014966
12.

Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis.

An J, Alemao E, Reynolds K, Kawabata H, Solomon DH, Liao KP, Niu F, Cheetham TC.

J Rheumatol. 2016 Nov;43(11):1989-1996.

PMID:
27585690
13.

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.

Feldman CH, Liu J, Feldman S, Solomon DH, Kim SC.

Lupus. 2016 Oct 31. pii: 0961203316672928. [Epub ahead of print]

PMID:
27799438
14.

Editorial: The Enduring Value of Reporting Randomized Controlled Clinical Trials in Arthritis & Rheumatology: 2016 and Beyond.

Solomon DH, Bucala RJ.

Arthritis Rheumatol. 2016 Dec;68(12):2831-2833. doi: 10.1002/art.39845. No abstract available.

PMID:
27788296
15.

Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study.

Choi NK, Solomon DH, Tsacogianis TN, Landon JE, Song HJ, Kim SC.

J Bone Miner Res. 2016 Oct 13. doi: 10.1002/jbmr.3019. [Epub ahead of print]

PMID:
27736041
16.

Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Khan NF, Lee M, Vachon A, Iliadis TL, Hollands W, Doheny S, Elman S, Kraft JM, Naseem S, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.

Am Heart J. 2016 Oct;180:90-7. doi: 10.1016/j.ahj.2016.07.017.

PMID:
27659887
17.

Gout and Risk of Fracture in Women: A Prospective Cohort Study.

Paik JM, Kim SC, Feskanich D, Choi HK, Solomon DH, Curhan GC.

Arthritis Rheumatol. 2016 Sep 2. doi: 10.1002/art.39852. [Epub ahead of print]

PMID:
27589491
18.

Comparative Rates of Serious Infections among Patients with Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Feldman CH, Marty FM, Winkelmayer WC, Guan H, Franklin JM, Solomon DH, Costenbader KH, Kim SC.

Arthritis Rheumatol. 2016 Sep 2. doi: 10.1002/art.39849. [Epub ahead of print]

PMID:
27589220
19.

Gout and the Risk of Non-vertebral Fracture.

Kim SC, Paik JM, Liu J, Curhan GC, Solomon DH.

J Bone Miner Res. 2016 Aug 19. doi: 10.1002/jbmr.2978. [Epub ahead of print]

PMID:
27541696
20.

A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.

Danila MI, Outman RC, Rahn EJ, Mudano AS, Thomas TF, Redden DT, Allison JJ, Anderson FA, Anderson JP, Cram PM, Curtis JR, Fraenkel L, Greenspan SL, LaCroix AZ, Majumdar SR, Miller MJ, Nieves JW, Safford MM, Silverman SL, Siris ES, Solomon DH, Warriner AH, Watts NB, Yood RA, Saag KG.

Contemp Clin Trials Commun. 2016 Dec 15;4:14-24.

PMID:
27453960
Items per page

Supplemental Content

Loading ...
Support Center